9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Adela, Inc
Massive Bio, Inc.
Tempus AI
Taproot Health
Sanguine Biosciences
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Celgene
Amgen
Amgen
Valerio Therapeutics
Altor BioScience